Anogenital warts are one of the most common sexually transmitted infections, caused by specific types of human papillomavirus (HPV). While the warts themselves are not dangerous, they can cause significant distress and discomfort. Treatment approaches range from patient-applied creams to clinical procedures, and new therapies continue to be explored in research settings.

Understanding Treatment Goals and Options

When someone receives a diagnosis of anogenital warts, the primary goal of treatment is to remove visible warts and relieve any symptoms they may be causing. Many people seek treatment not only because of physical discomfort—such as itching, bleeding, or pain during sexual activity—but also because the appearance of warts can cause considerable emotional distress. The psychological impact of having visible warts can affect self-esteem, create anxiety about cancer risk, and strain intimate relationships.^[1]

It is important to understand that treatment does not cure the underlying HPV infection itself. The virus may remain in the body even after warts are successfully removed. What treatment can do is eliminate visible warts, potentially reduce the amount of virus present, and help patients feel more comfortable both physically and emotionally. The choice of treatment depends on several factors, including the number of warts, their size and location, patient preference, cost, convenience, potential side effects, and the healthcare provider’s experience with different methods.^[2]

An important consideration is that anogenital warts can sometimes resolve on their own without any intervention. If left untreated, warts might disappear spontaneously (often within less than one year), remain unchanged, or increase in size or number. For some patients, an acceptable approach is to wait and see if the warts resolve naturally. However, this decision should be made together with a healthcare provider, taking into account individual circumstances and preferences.^[2]

Standard Treatment Approaches

Treatment for anogenital warts falls into two main categories: therapies that patients can apply themselves at home, and procedures that must be performed by healthcare professionals in a clinical setting. Both approaches have been used successfully for many years, and there is no definitive evidence that one is superior to another for all patients or all types of warts.^[2]

Patient-Applied Treatments

Patient-applied therapies offer the convenience of home treatment and give patients more control over their care. These medications work by directly destroying wart tissue or by stimulating the body’s immune response against the virus. However, they require careful adherence to instructions and may take several weeks to show results.^[10]

Podofilox (also known as podophyllotoxin) is a plant-derived compound that works by stopping the growth of wart cells. It comes as a solution or gel that patients apply directly to external genital warts. The typical regimen involves applying the medication twice daily for three consecutive days, followed by four days of rest. This weekly cycle continues for up to four weeks. Podofilox is recommended mainly for external penile skin, as it can be irritating when applied to skin folds such as under the foreskin or on vulvar skin. It should not be used during pregnancy. Common side effects include local irritation, burning sensation, and inflammation at the application site.^[10][18]

Imiquimod cream works differently from podofilox—instead of directly destroying wart tissue, it stimulates the body’s immune system to fight the HPV infection. This immunomodulator (a substance that modifies immune responses) is applied to external genital and perianal warts. Patients typically apply the cream once daily at bedtime, three times per week, and wash it off after six to ten hours. Treatment continues until the warts clear up or for a maximum of 16 weeks. Imiquimod is considered easy to use and safe when instructions are followed carefully. Side effects may include redness, swelling, itching, burning, and skin erosion at the application site. Like podofilox, imiquimod is not recommended for use during pregnancy.^[10][18]

Provider-Applied Treatments

Healthcare providers can perform various procedures to remove genital warts. These treatments are typically performed in a clinical setting and often require multiple visits to achieve complete wart clearance.^[11]

Cryotherapy, or freezing therapy, is one of the most common and effective first-line treatments for anogenital warts. A healthcare provider uses liquid nitrogen to freeze the warts, causing the treated tissue to die and eventually fall off. The provider may use an open spray technique or a cotton-tipped applicator, applying the freezing agent for 10 to 15 seconds. Treatment is typically repeated every one to two weeks until the warts are gone. Cryotherapy has high response rates, with clearance occurring in about 75% of cases. The procedure can be uncomfortable and may cause pain, erosion, ulceration, and temporary skin discoloration. However, cryotherapy is considered safe for use during pregnancy.^[15]

Trichloroacetic acid (TCA) is a chemical solution that destroys wart tissue on contact. A trained healthcare professional applies this caustic agent directly to the surface of the warts. The treatment may need to be repeated weekly, and the provider must take care to avoid contact with normal surrounding skin. TCA can be used on various types of genital warts and is safe during pregnancy. However, this treatment is not available in all healthcare settings.^[18]

Surgical excision involves cutting out the warts after numbing the area with local anesthetic. This method has among the highest success rates (63-91%) and lowest recurrence rates of all treatment options. The procedure is particularly useful for larger warts or when other treatments have failed. Potential drawbacks include the need for anesthesia, possible scarring, and the risk of infection or bleeding.^[15]

Electrodesiccation uses heat from an electrical current to destroy wart tissue. After numbing the area, the provider applies an electrode to the wart, which burns and dries out the tissue. This procedure is often combined with curettage (scraping away the dead tissue). Healthcare providers must use proper protective equipment because the smoke plume created during electrodesiccation may contain infectious particles.^[15]

Carbon dioxide laser treatment is reserved for extensive or recurrent warts that have not responded to other therapies. The laser beam vaporizes the wart tissue with precision. This method requires local, regional, or sometimes general anesthesia. While effective, laser treatment is more expensive and technically demanding than other options.^[15]

The duration of treatment varies considerably depending on the method chosen and individual response. Some treatments like surgical excision can remove warts in a single session, while others such as cryotherapy or patient-applied creams may require several weeks or months of repeated applications before complete clearance is achieved. Healthcare providers typically recommend follow-up evaluation two to three months after completing treatment.^[12]

All treatment methods carry the risk of side effects. Common adverse effects include pain, irritation, burning sensation, skin erosion, ulceration, scarring, and changes in skin pigmentation. More serious but rare complications can include infection and allergic reactions to medications. It is also important to understand that even after successful treatment, warts may recur. Recurrence happens because treatment removes visible warts but may not completely eliminate the HPV infection from the surrounding skin.^[10]

Treatment in Clinical Trials

While standard treatments for anogenital warts are well-established, researchers continue to explore new and potentially more effective therapies through clinical trials. These investigational treatments aim to improve cure rates, reduce recurrence, and offer more convenient or less invasive options for patients.^[14]

Clinical trials for genital warts typically progress through different phases. Phase I trials focus primarily on safety, testing new treatments in small groups to identify appropriate doses and potential side effects. Phase II trials expand to larger groups and begin to evaluate whether the treatment actually works against genital warts. Phase III trials involve even larger numbers of participants and compare the new treatment directly with standard therapies to determine if it offers advantages.^[14]

While specific innovative molecules or therapies currently being tested in clinical trials for anogenital warts were not detailed in the available sources, research in this area continues. Studies often explore modifications of existing treatments, new combinations of therapies, enhanced delivery methods for medications, and approaches to strengthen the immune response against HPV. Some research focuses on preventing wart recurrence after successful treatment, while other studies investigate treatments specifically for patients who have not responded to standard therapies.^[14]

The HPV vaccine represents an important preventive approach that has been extensively studied and is now widely recommended. Vaccination programs in multiple countries, including the United States, have demonstrated remarkable success in reducing the incidence of anogenital warts among adolescents, young women, and heterosexual men. The vaccine works by helping the immune system recognize and fight off HPV types 6 and 11 (which cause most genital warts) as well as high-risk cancer-causing HPV types. Vaccines are most effective when administered before a person becomes sexually active, typically recommended for individuals aged 9 to 26 years.^[2][7]

Sometimes healthcare providers use combination therapy, applying more than one treatment approach at the same time. For example, a provider might perform cryotherapy during office visits while the patient applies a topical medication at home between appointments. The rationale is that combining different mechanisms of action might improve overall effectiveness. However, limited data exist regarding the efficacy or risk for complications associated with combination therapy, so this approach should only be undertaken under close medical supervision.^[2]

Most common treatment methods

• Patient-applied topical medications
  • Podofilox solution or gel applied twice daily for three consecutive days, followed by four days of rest, repeated for up to four weeks
  • Imiquimod cream applied three times weekly at bedtime for up to 16 weeks to stimulate immune response
  • Both require careful adherence to application instructions and can cause local irritation
• Cryotherapy (freezing treatment)
  • Liquid nitrogen applied by healthcare provider to freeze and destroy wart tissue
  • Treatment repeated every one to two weeks until warts clear
  • Clearance occurs in approximately 75% of cases
  • Safe for use during pregnancy
• Surgical removal
  • Warts cut out under local anesthetic
  • Highest success rates (63-91%) and lowest recurrence rates
  • May cause scarring but effective for large or resistant warts
• Destructive procedures
  • Electrodesiccation uses electrical current to burn away wart tissue
  • Carbon dioxide laser vaporizes warts, reserved for extensive or recurrent cases
  • Trichloroacetic acid chemically destroys wart tissue on contact
• HPV vaccination
  • Prevents infection with HPV types that cause most genital warts
  • Most effective when given before sexual activity begins
  • Has significantly reduced genital warts incidence in vaccinated populations